Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts.

Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Abstract Text:

    brian d kulbershBrian D Kulbersh,ryan d duncanRyan D Duncan,j scott magnusonJ Scott Magnuson,joni b skipperJoni B Skipper,kurt zinnKurt Zinn,eben l rosenthalEben L Rosenthal,

    OBJECTIVES: To determine whether fluorescently labeled anti-epidermal growth factor (EGFR) antibody could be used to detect residual disease and to guide surgical resections by comparing the sensitivity and specificity of optical fluorescence imaging with the sensitivity and specificity of histopathologic evaluation. DESIGN: A preclinical model of head and neck squamous cell carcinoma. SUBJECTS: Mice xenografted with SCC-1 tumor cells. INTERVENTIONS: The mice underwent systemic injection with anti-EGFR antibody (cetuximab) conjugated to an optically active fluorophore (Cy5.5). Both a subcutaneous flank model (n = 18) and an orthotopic murine model (n = 15) were used to assess for the presence of residual disease by fluorescent stereomicroscopy after subtotal resections of tumors. Histologic analysis was performed to confirm the presence or absence of disease. RESULTS: In the subcutaneous flank model, a diagnostic dose (50 microg) and therapeutic dose (250 microg) of fluorescent-labeled anti-EGFR were administered. When a diagnostic dose was given, the sensitivity was 86%, which was less than the 91% sensitivity when the higher dose was given. Tumor biopsy specimens in which disease was detected by histologic analysis but not by fluorescence (false-negative result) averaged 166 cells (range, 50-350 cells). The specificity of optical fluorescence to predict the presence of tumor in both groups was 100%. In the floor of the mouth model, we demonstrated a sensitivity of 81% and a specificity of 100%. False-negative results were obtained in a tumor fragment measuring less than 0.5 mm in diameter. CONCLUSION: These data support further investigation of fluorescently labeled anti-EGFR antibody to detect disease in the surgical setting.

    Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Publishing Authors By Initials

    bd kulbershBD Kulbersh,rd duncanRD Duncan,js magnusonJS Magnuson,jb skipperJB Skipper,k zinnK Zinn,el rosenthalEL Rosenthal,

    For similar surgical procedures, operative: transplantation: transplantation, heterologous research abstracts see: surgical procedures, operative: transplantation: transplantation, heterologous research

    PUBMED ID PMID:

    MEDLINE DATE:

    Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Archives of otolaryngology--head & neck surgery

    VOLUME: 133

    Page Numbers: 511-5

    Journal Abbreviation: Arch. Otolaryngol. Head Neck S

    ISSN: 0886-4470

    DAY: 3

    MONTH: May

    YEAR: 2007

    Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8603209

    Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Keywords Mesh Terms:

    KEYWORDS: Transplantation, Heterologous

    MESH TERMS: methods

    Chemical & Substance for Abstract: Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Information

    Substance Name: Epidermal Growth Factor

    Registry Number: 62229-50-9

    Grant and Affiliation Information for Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts.

    AFFILIATION: Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, AL 35294-0012, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: P30 CA13148

    ACRONYM: CA

    MEDLINETA: Arch Otolaryngol Head Neck Sur

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News